MD&A · 2024
In this section4 topics
Overview of Operations
Overview of Operations
In the fiscal year 2024, the Company performance improved significantly due to higher medical revenues which generated from the increase in both number of visit and revenue per visit/ revenue per case due to more complex treatments. The Company reported total revenues of Baht 4,690.5 million, an increase of 10.3% from 2023 which reported total revenues of Baht 4,252.8 million. The profit for the year 2024 was Baht 712.7 million or net profit margin of 15.2%, an increase of 27.8% from 2023 which reported profit for the year of Baht 557.9 million or net profit margin of 13.1%.
Operating Results & Financial Condition
Operating Results & Profitability
Revenue
(1) Revenues from Hospital Operations
In 2024, the Company reported revenues from hospital operations of Baht 4,635.4 million an increase 10.3% from Baht 4,202.0 million in 2023. Revenue from medical services were 98.8% of total revenues in 2024 and 98.8 % of total revenues in 2023.
The out-patient revenues (OPD revenue) increased by 9.6% compared to last year. The increase was primarily due to an increase in both the number of outpatient visits and revenue per visit. The in-patient revenue (IPD revenue) increased by 11.3% compared to last year. The major increase was primarily due to an increase in revenue per patient day while there was a little bit of an increase in number of patient days.
(2) Other Revenues
Other revenues of the Company consist of rental revenues and others such as service fees, rental fees from dormitory provided for staff, dividend received, profit from available for-sale security, etc. In 2024, the Company’s other revenues were Baht 55.1 million or 1.2% of total revenue. Meanwhile, other revenues of Year 2023 were Baht 50.8 million, representing 1.2% of total revenues.
Expenses
(1) Cost of Hospital Operations
In the fiscal year 2024, the Company reported the cost of hospital operations (including depreciation and amortization) of Baht 3,045.4 million or equal to 65.7% of medical revenues while the Company reported cost of hospital operations (including depreciation and amortization) of year 2023 Baht 2,820.0 million or equal to 67.1% of medical revenues.
(2) Selling and Administrative Expenses
In the fiscal year 2024, the Company reported the selling and administrative expenses (including depreciation and amortization) of Baht 837.2 million or equal to 17.8% of total revenues while the Company reported the selling and administrative expenses (including depreciation and amortization) of year 2023 Baht 773.7 million or equal to 18.2% of total revenues. The significant decreases in percentage of cost of hospital operation including selling and administrative expenses were mainly from process improvements, cost management, incurring of economy of scale when revenue scaling up since some type of expense was fixed cost.
Profitability and Profitability Margin
For the year 2024, the Company reported earnings before interest, tax, depreciation and amortization (EBITDA) Baht 1,114.3 million with 23.8% of EBITDA margin. In year 2023, the Company reported earnings before interest, tax, depreciation and amortization (EBITDA) Baht 958.0 million with 22.5% of EBITDA margin.
For the year 2024, the Company reported depreciation and amortization of Baht 306.4 million, an increase 2.5% compared to 2023 of Baht 298.9 million.
In the fiscal year 2024, the Company reported Finance income of Baht 54.6 million, increased by 80.8% compared to year 2023 which reported Finance income of Baht 30.2 million. The major increase was mainly from reshuffle of excess cash to invest in fixed deposits at banks and debt instruments to get a higher yield of interest.
In the fiscal year 2024, the Company reported Finance cost of Baht 0.5 million, decreased by 16.7% compared to year 2023 which reported Finance cost of Baht 0.6 million resulting from an application of IFRS 16, lease liabilities.
In the fiscal year 2024, the Company reported Income tax expenses of Baht 149.3 million, increased by 14.1% compared to year 2023 which reported Income tax expenses of Baht 130.8 million. During 4th quarter of year 2024, the Company received tax privilege from Board of Investment Thailand since the Company offered support to community according to BOI condition.
The Company reported net profit for the year 2024 of Baht 712.7 million, representing the net profit margin 15.2% of total revenue, increased by 27.8% compared to year 2023 which reported net profit Baht 557.9 million, representing the net profit margin 13.1% of total revenue. Basic earnings per share of Baht 0.91 per share and Baht 0.71 per share in 2024 and 2023 respectively.
Liquidity & Capital Adequacy
Cash Flow
Sources and uses of cash flow in operating, investing and financing comprise of:
(1) Cash flow from operating
In the fiscal year 2024, the Company reported cash flows from operating activities of Baht 1,039.8 million, increased by Baht 235.7 million compared to the last year of Baht 804.1 million.
(2) Cash flow from investing
In the fiscal year 2024, the Company reported cash flows used in investing activities of Baht 2,038.2 million. This was mainly due to the increase in fixed deposits at banks equity and debt instruments incurred during the year Baht 1,790.1 million. An acquisition of fixed assets during the year was Baht 249.2 million. The Company reported cash flows from investing activities of Baht 377.9 million in year 2023 which major investment were from fixed deposits at banks equity and debt instruments incurred during the year Baht 71.8 million. An acquisition of fixed assets during the year was Baht 306.1 million.
(3) Cash flow from financing
In the fiscal year 2024, the Company reported cash flows used in financing activities of Baht 357.7 million which mainly was the dividend payment and payment of lease liabilities compared to the year 2023 which reported cash flows used in financing activities of Baht 240.3 million.
Cash and Cash Equivalent
The Company had an outstanding balance of cash and cash-equivalent Baht 394.8 million as of 31 December 2024 which decreased by Baht 1,356.1 million from Baht 1,750.9 million as of 31 December 2023.
Asset Management Capability
Total Assets
The Company’s total assets consist of 2 main categories as follows:
(1) Current assets such as cash and cash-equivalent, trade receivable and others receivable, medicines, medical supplies and inventory, and other current assets, etc.
(2) Non-current assets such as property, plant and equipment, intangible assets other non-current assets, etc.
Accordingly, the Company’s overall assets primarily consist of land, building and equipment, temporary investment, cash and cash-equivalent, trade receivable and others receivable and other current financial assets.
As of 31 December 2024, the Company reported current assets of Baht 2,657.5 million, increased by 18.0% compared to Baht 2,251.5 million as of 31 December 2023. This resulted from an increase in current financial assets due to reshuffle of excess cash to invest in fixed deposits at banks and debt instruments to get a higher yield of interest.
As of 31 December 2024, the Company reported non-current assets of Baht 3,741.6 million, increased by 2.3% compared to Baht 3,658.6 million as of 31 December 2023.
Liabilities
Majority liabilities of the Company consist of trade and other payables and provision for long-term employee benefits.
As of 31 December 2024, the Company reported current liabilities of Baht 757.7 million, increased by 19.9% compared to Baht 632.0 million as of 31 December 2023. This resulted from an increase in advance revenue from selling prepaid check-up vouchers, which customers had not yet used and from drug and medical supply trade creditors whose payments are not yet due.
As of 31 December 2024, the Company reported non-current liabilities of Baht 202.8 million, increased by 2.2% compared to Baht 198.4 million as of 31 December 2023.
Shareholders’ equity
As of 31 December 2024, the Company reported shareholders’ equity of Baht 5,438.5 million, increased by 7.1% compared to Baht 5,079.7 million as of 31 December 2023. This was mainly from net profit for the year of Baht 712.7 million offsetting with a dividend payment from operating result year 2024 of Baht 235.9 million and interim dividend payment year 2024 of Baht 117.9 million.
Debt Securities with Financial Ratio Requirements
Debt Securities with Financial Ratio Requirements Issued?
No
Factors That May Affect Financial Condition
Factors or Incidents That May Materially Affect Financial Condition
Factors or Events That Might Significantly Impact Future Financial Position or Performance
1. Trends, Factors, and Impacts on Environmental, Social, and Governance (ESG) Aspects
Amidst challenging environmental and social changes, Praram 9 Hospital has proactively planned and implemented comprehensive measures across environmental, social, and governance (ESG) aspects to ensure sustainable operations. Investments in technology and innovation to enhance service efficiency, along with adapting to carbon tax measures and new financial reporting standards, enable the hospital to maintain a leadership position in the market while effectively and transparently meeting patient needs. Key sustainability considerations are integrated into the hospital’s strategic planning and risk assessment processes, with set targets for carbon neutrality, net-zero greenhouse gas emissions, and long-term organizational goals by 2065.
2. Factors Affecting Financial Position
1. Carbon Taxation The implementation of carbon taxation policies may lead to increased costs for companies with high greenhouse gas emissions, impacting profitability and long-term operations. Companies must therefore adjust their strategies to reduce emissions and enhance energy efficiency to mitigate these financial impacts.
2. IFRS S1 and IFRS S2 Financial Standards The adoption of IFRS S1 (General Requirements for Disclosure of Sustainability-related Financial Information) and IFRS S2 (Climate-related Disclosures) will enhance the transparency of financial and sustainability-related disclosures, as well as climate risk information. Companies may need to improve their ESG measurement and reporting systems, along with assessing financial risks and opportunities related to environmental and social factors. Overall, these factors will significantly impact the company’s financial position and operations in the future. To effectively and sustainably adapt, companies must refine their strategic approaches and internal management systems to comply with new standards and mitigate risks arising from policy and environmental changes.

